Tuesday , October 26 2021

First human trial to evaluate vaccine against COVID-19 begins in US

The first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle, US health officials said.

The US National Institutes of Health (NIH) said in a statement that the open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccine yesterday.

Please share this news
<div id="taboola-below-article-thumbnails"></div>
<script type="text/javascript">
  window._taboola = window._taboola || [];
  _taboola.push({
    mode: 'thumbnails-a',
    container: 'taboola-below-article-thumbnails',
    placement: 'Below Article Thumbnails',
    target_type: 'mix'
  });
</script>